Chief Scientific Officer of LifeARC (United Kingdom)
Date of birth: July 29, 1958
First elected: May 2017
Term expires: General Meeting 2021
Business address: 54, rue la Boétie – 75008 Paris (France)
Independent director / Member of the Scientific Committee / Member of the Appointments, Governance and CSR Committee
Education and business experience
Melanie Lee is Chief Scientific Officer of LifeARC (United Kingdom).
She worked as a molecular genetics postdoc, first at Imperial College London on yeast and then from 1985 with Sir Paul Nurse, a Nobel Prize winner, at the Imperial Cancer Research Fund’s Lincoln’s Inn Laboratories. Following her academic career she spent 10 years at Glaxo/GlaxoWellcome (1988-1998). In 1998, Melanie joined Celltech plc as Executive Director of Research. Celltech plc was subsequently acquired by UCB where she became Executive Vice President, Research & Development. After leaving UCB in 2009 she had a successful tenure as CEO at Syntaxin Ltd, a UK based biotech and following the sale to Ipsen, founded NightstaRx Ltd, a Syncona backed company in 2014.
Melanie received her CBE for services to medical science in 2009.
Melanie Lee received an undergraduate degree in Biology from the University of York and then a Ph.D. at National Institute for Medical Research in London.
Directorships and appointments outside the Sanofi Group
Directorships as of 12/31/2019
- Director of Think10 (United Kingdom)
(*) Listed companies are indicated by an asterisk.